Addressing inter-device variations in optical coherence tomography angiography: will image-to-image translation systems help?

por Nouri, Hosein, Nasri, Reza, Abtahi, Seyed-Hossein
Publicado 2023

Successful seroconversion following mild COVID-19 contraction in a double-vaccinated B-cell-depleted person with multiple sclerosis: A hint towards booster efficacy?

por Etemadifar, Masoud, Nouri, Hosein, Salari, Mehri, Sedaghat, Nahad
Publicado 2021

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acut...

por Etemadifar, Masoud, Nouri, Hosein, Salari, Mehri, Sedaghat, Nahad
Publicado 2022

Are inner nuclear layer ischemic lesions hidden indicators of retinal vein occlusion risk? A case-control study

por Nourinia, Ramin, Mashhadi, Seyed Mohammadjavad, Abtahi, Seyed-Hossein, Nouri, Hosein
Publicado 2023

Movement Disorders Associated with COVID-19

por Salari, Mehri, Zaker Harofteh, Bahareh, Etemadifar, Masoud, Sedaghat, Nahad, Nouri, Hosein
Publicado 2021

Eye Disorders in the Post-COVID Era

por Abtahi, Seyed-Hossein, Nouri, Hosein, Moradian, Siamak, Yazdani, Shahin, Ahmadieh, Hamid
Publicado 2021

The effect of vitamin D supplementation on the outcome of treatment with bevacizumab in diabetic macular edema: a randomized clinical trial

por Fekri, Sahba, Soheilian, Masoud, Roozdar, Sepehr, Abtahi, Seyed-Hossein, Nouri, Hosein
Publicado 2022

Effect of multiple sclerosis disease-modifying therapies on the real-world effectiveness of two doses of BBIBP-CorV (Sinopharm) vaccine

por Etemadifar, Masoud, Abhari, Amir Parsa, Nouri, Hosein, Eighani, Naghme, Salari, Mehri, Sedaghat, Nahad
Publicado 2023

Inverted ILM Flap Technique in Optic Disc Pit Maculopathy

por Tavallali, Ali, Sadeghi, Yasaman, Abtahi, Seyed-Hossein, Nouri, Hosein, Samadikhadem, Sanam, Rezaei, Mitra, Mazloumi, Mehdi
Publicado 2023

Intravitreal Injections and Face Masks: Endophthalmitis Risk Before and During the COVID-19 Pandemic

por Karimi, Saeed, Nikkhah, Homayoun, Mohammadzadeh, Amir, Ramezani, Alireza, Ansari, Iman, Nouri, Hosein, Abtahi, Seyed-Hossein
Publicado 2023

Post-COVID-19 acute disseminated encephalomyelitis: Case report and review of the literature

por Etemadifar, Masoud, Mansouri, Amir Reza, Nouri, Hosein, Sedaghat, Nahad, Salari, Mehri, Maghsoudi, Milad, Heydari, Narges
Publicado 2022

Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study

por Etemadifar, Masoud, Abhari, Amir Parsa, Nouri, Hosein, Salari, Mehri, Maleki, Shiva, Amin, Alireza, Sedaghat, Nahad
Publicado 2022

Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study

por Sedaghat, Nahad, Etemadifar, Masoud, Nouri, Hosein, Abhari, Amir Parsa, Maleki, Shiva, Amin, Alireza, Salari, Mehri
Publicado 2022

Quantitative Magnetic Resonance Imaging Analysis of Early Markers of Upper Cervical Cord Atrophy in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

por Adibi, Iman, Najafi, Afshin, Merajifar, Fouad, Ramezani, Neda, Nouri, Hosein, Jalilvand, Nassim, Ashtari, Fereshteh, Vard, Alireza, Shaygannejad, Vahid
Publicado 2021

SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine

por Etemadifar, Masoud, Sedaghat, Nahad, Nouri, Hosein, Lotfi, Noushin, Chitsaz, Ahmad, Khorvash, Reza, Zolfaghari, Hamed, Ghasemi Movaghar, Alireza, Pourabbas, Mohammad, Salari, Mehri
Publicado 2022

Epidemiological and clinical features of pediatric-onset multiple sclerosis: A population-based study in Isfahan, Iran, between 1997-2020

por Etemadifar, Masoud, Abhari, Amir Parsa, Yadegarfar, Ghasem, Salari, Mehri, Ghazavi, Mohammadreza, Rayani, Milad, Nouri, Hosein, Kargaran, Parisa, Mazaheri, Shahrbanoo, Saadat, Homa
Publicado 2021

Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis

por Etemadifar, Masoud, Abhari, Amir Parsa, Nouri, Hosein, Sigari, Amirhossein Akhavan, Piran Daliyeh, Seyed Mohammad, Maracy, Mohammad Reza, Salari, Mehri, Maleki, Shiva, Sedaghat, Nahad
Publicado 2022

COVID-19 and the Risk of Relapse in Multiple Sclerosis Patients: A Fight with No Bystander Effect?

por Etemadifar, Masoud, Sedaghat, Nahad, Aghababaee, Ali, Kargaran, Parisa K, Maracy, Mohammad Reza, Ganjalikhani-Hakemi, Mazdak, Rayani, Milad, Abhari, Amir Parsa, Khorvash, Reza, Salari, Mehri, Nouri, Hosein
Publicado 2021